Application of microbiological quantitative methods for evaluation of changes in the amount of bacteria in patients with wounds and purulent fistulas subjected to phage therapy and for assessment of phage preparation effectiveness (in vitro studies)

Advances in Medical Sciences

Volumn 58, Issue 2, 2013, Pages 257-264

  Lecion, D ^a   Fortuna, W ^a   Dabrowska K ^a   Miedzybrodzki R ^a   Weber Dabrowska B ^a   Gorski A ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Bacteriophages; Phage preparation; Phage therapy; Purulent fistula; Wound infection

Indexed keywords

AGAR; GENTAMICIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL COUNT; BACTERIOPHAGE; CHRONIC WOUND; CLINICAL ARTICLE; CONTROLLED STUDY; FISTULA; HUMAN; IN VITRO STUDY; NONHUMAN; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

BACTERIOLOGICAL TECHNIQUES; BACTERIOPHAGES; CHRONIC DISEASE; COLONY COUNT, MICROBIAL; FISTULA; HUMANS; SPECIMEN HANDLING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

EID: 84896860624     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/ams-2013-0004     Document Type: Article

References (30)

1. Duckworth DH, Gulig PA. Bacteriophages: potential treatment for bacterial infections. BioDrugs. 2002;16(1):57-62.
2. Górski A, Miedzybrodzki R, Borysowski J, Weber- Dabrowska B, Lobocka M, Fortuna W, Letkiewicz S, Zimecki M, Filby G. Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs. 2009 Aug;10(8):766-74.
3. Kutateladze M, Adamia R. Phage therapy experience at the Eliava Institute. Med Mal Infect. 2008 Aug;38(8):426-30.
4. Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 2010 Dec;28(12):591-5.
5. Miȩdzybrodzki R, Borysowski J, Weber-D?browska B, Fortuna W, Letkiewicz S, Szufnarowski K, Pawe?czyk Z, Rogó? P, K?ak M, Wojtasik E, Górski A. Clinical aspects of phage therapy. Adv Virus Res. 2012;83:73-121.
6. Wright A, Hawkins CH, Anggard EE, Harper DR. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol. 2009 Aug;34(4):349-57.
7. Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care. 2009 Jun;18(6):237-8, 240-3.
8. Bruttin A, Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 2005 Jul;49(7):2874-8.
9. Sarker SA, McCallin S, Barretto C, Berger B, Pittet AC, Sultana S, Krause L, Huq S, Bibiloni R, Bruttin A, Reuteler G, Brüssow H. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology. 2012 Dec 20;434(2):222-32.
10. Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, Górski A. A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med. 2009 Dec;9(4):303-12.
11. Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, Górski A. Bacteriophage therapy in children: facts and prospects. Med Sci Monit. 2008 Aug;14(8):RA126-32.
12. Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, Górski A. Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. Postepy Hig Med Dosw (Online). 2007 Aug 3;61:461-5.
13. Holder JA. Nonusefulness of quantitative wound cultures. Clin Microbiol Newsletter. 1997; 19(6):45-48.
14. Kowalska-Krochmal B. Znaczenie badan mikrobiologicznych u pacjentow z ranami przewleklymi. Diagnosta Laboratoryjny. 2008 Apr-May;1(16):10-12. Polish.
15. Steer JA, Papini RP, Wilson AP, McGrouther DA, Parkhouse N. Quantitative microbiology in the management of burn patients. I. Correlation between quantitative and qualitative burn wound biopsy culture and surface alginate swab culture. Burns. 1996 May;22(3):173-6.
16. Dow G. Bacterial swabs and the chronic wound: when, how, and what do they mean? Ostomy Wound Manage. 2003 May;49(5A Suppl):8-13.
17. Gardner SE, Frantz RA, Saltzman CL, Hillis SL, Park H, Scherubel M. Diagnostic validity of three swab techniques for identifying chronic wound infection. Wound Repair Regen. 2006 Sep-Oct;14(5):548-57.
18. Levine NS, Lindberg RB, Mason AD Jr, Pruitt BA Jr. The quantitative swab culture and smear: A quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma. 1976 Feb;16(2):89-94.
19. Buchanan K, Heimbach DM, Minshew BH, Coyle MB. Comparison of quantitative and semiquantitative culture techniques for burn biopsy. J Clin Microbiol. 1986 Feb;23(2):258-61.
20. Gardner SE, Frantz RA, Hillis SL, Park H, Scherubel M. Diagnostic validity of semi-quantitative swab cultures. Wounds. 2007; 19(2):31-38.
21. Landis SJ. Chronic wound infection and antimicrobial use. Adv Skin Wound Care. 2008 Nov;21(11):531-40; quiz 541-2.
22. Kirtland SH, Corley DE, Winterbauer RH, Springmeyer SC, Casey KR, Hampson NB, Dreis DF. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest. 1997 Aug;112(2):445-57.
23. Miño de Kaspar H, Kreutzer TC, Aguirre-Romo I, Ta CN, Dudichum J, Bayrhof M, Klauss V, Kampik A. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol. 2008 Jan;145(1):136-42.
24. Owens BD, Wenke JC. Early wound irrigation improves the ability to remove bacteria. J Bone Joint Surg Am. 2007 Aug;89(8):1723-6.
25. Bahrs C, Schnabel M, Frank T, Zapf C, Mutters R, von Garrel T. Lavage of contaminated surfaces: an in vitro evaluation of the effectiveness of different systems. J Surg Res. 2003 Jun 1;112(1):26-30.
26. Brown LL, Shelton HT, Bornside GH, Cohn I Jr. Evaluation of wound irrigation by pulsatile jet and conventional methods. Ann Surg. 1978 Feb;187(2):170-3.
27. Conroy BP, Anglen JO, Simpson WA, Christensen G, Phaup G, Yeager R, Gainor BJ. Comparison of castile soap, benzalkonium chloride, and bacitracin as irrigation solutions for complex contaminated orthopaedic wounds. J Orthop Trauma. 1999 Jun-Jul;13(5):332-7.
28. Abedon ST, Thomas-Abedon C. Phage therapy pharmacology. Curr Pharm Biotechnol. 2010 Jan;11(1):28-47.
29. Letarov AV, Golomidova AK, Tarasyan KK. Ecological basis for rational phage therapy. Acta Naturae. 2010 Apr;2(1):60-72.
30. Abedon S. Phage therapy pharmacology: calculating phage dosing. Adv Appl Microbiol. 2011;77:1-40.